Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted heterocyclic compounds as tropomyosin receptor kinase a (TrkA) inhibitors

Substituted heterocyclic compounds as tropomyosin receptor kinase a (TrkA) inhibitors

US Patent 9289419 · Granted Mar 22, 2016

Estimated economic value: $8,882,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibi2019
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists2018
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted pyrazolo[1,5-A] pyridine as tropomyosin receptor kinase (TrK) inhibi2018
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017
Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (T2017